Ginkgo Bioworks Holdings Inc

DNA16 Feb 2025
Healthcare
$14
+0.09 (+8.71%)
Lowest Today
$13.92
Highest Today
$15.33
Today’s Open
$14
Prev. Close
$13.55
52 Week High
$64.4
52 Week Low
$5.26
To Invest in Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc

Healthcare
DNA16 Feb 2025
+0.09 (+8.71%)
1M
3M
6M
1Y
5Y
Low
$13.92
Day’s Range
High
$15.33
13.92
52 Week Low
$5.26
52-Week Range
52 Week High
$64.4
5.26
1 Day
-
1 Week
+9.58%
1 month return
+44.55%
3 month return
+133.12%
6 month return
+67.48%
1 Year return
+909.93%
3 Years return
+171.54%
5 Years return
-
10 Years return
-
Institutional Holdings
Nikko Gbl All Biological Genome Eq MF
8.65
Viking Global Investors LP
6.22
Baillie Gifford & Co Limited.
5.84
Vanguard Group Inc
4.53
Scottish Mortgage Ord
4.16
Anchorage Advisors, LLC
3.04
Legal & General Group PLC
2.49

Market Status

Fundamentals
Market Cap
846.66 mln
PB Ratio
0.98
PE Ratio
0
Enterprise Value
608.22 mln
Total Assets
1665.34 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Organisation
Ginkgo Bioworks Holdings Inc
Employees
1218
Industry
Biotechnology
CEO
Dr. Jason  Kelly Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities